BFEC
AMED

Benjamin F. Edwards & Company’s Amedisys AMED Stock Holding History

Benjamin F. Edwards & Company’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$5K Sell
57
-18
-24% -$1.67K ﹤0.01% 1859
2024
Q1 		$7K Sell
75
-11
-13% -$1.03K ﹤0.01% 1764
2023
Q4 		$8K Buy
+86
New +$8.03K ﹤0.01% 1707

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Benjamin F. Edwards & Company's AMED Position: Q2 2024 in Review

Benjamin F. Edwards & Company reduced its Amedisys (AMED) stake by 24% in Q2 2024, selling an estimated $1.67K and leaving 57 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #1859.

Benjamin F. Edwards & Company first reported a position in AMED in Q4 2023 and has held it in 3 quarters since. The position peaked at $8K in Q4 2023. 289 funds tracked by Wall St. Rank hold AMED as of Q2 2024.

  • Benjamin F. Edwards & Company held 57 shares of Amedisys worth $5K as of Q2 2024.
  • Benjamin F. Edwards & Company sold 18 Amedisys shares in Q2 2024, an estimated $1.67K.
  • Amedisys made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1859 holding.
  • Benjamin F. Edwards & Company first reported a position in Amedisys in Q4 2023 and has held it in 3 quarters since.
  • Benjamin F. Edwards & Company's Amedisys position peaked at $8K in Q4 2023.
  • 289 funds tracked by Wall St. Rank held Amedisys as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.